PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIntermedine
Intermedine
Intermedine is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target calcitonin receptor and calcitonin gene-related peptide type 1 receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
204 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple sclerosisD009103EFO_0003885G35—123—5
Rheumatoid arthritisD001172EFO_0000685M06.9—1—124
SarcoidosisD012507EFO_0000690D80-D89———314
ProteinuriaD011507—R80—112—4
Nephrotic syndromeD009404EFO_0004255N04—112—4
SclerosisD012598———121—3
Intermediate uveitisD015867EFO_1000986——1—2—3
Posterior uveitisD015866EFO_1001119——1—2—3
UveitisD014605EFO_1001231H20.9—1—2—3
Membranous glomerulonephritisD015433EFO_0004254N03.21——1—2
Show 16 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Amyotrophic lateral sclerosisD000690EFO_0000253G12.21—21——2
Kidney diseasesD007674EFO_0003086N08111——2
RecurrenceD012008———11——1
SyndromeD013577————1——1
NephrosisD009401————1——1
FatigueD005221—R53.83——1——1
Relapsing-remitting multiple sclerosisD020529EFO_0003929———1——1
Iga glomerulonephritisD005922EFO_0004194———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Duchenne muscular dystrophyD020388EFO_0000429——1———1
Muscular dystrophiesD009136EFO_0000757G71.0—1———1
DermatomyositisD003882EFO_0000398M33—1———1
PolymyositisD017285EFO_0003063M33.2—1———1
Respiratory distress syndromeD012128EFO_1000637J80—1———1
Chronic progressive multiple sclerosisD020528EFO_0003840——1———1
GlomerulonephritisD005921—N0511———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Proliferative vitreoretinopathyD018630EFO_1001129—1————1
NeuritisD009443——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ArthritisD001168EFO_0005856M05-M14————22
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIntermedine
INNintermedine
Description
INTERMEDINE
Classification
Protein
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C
Identifiers
PDB—
CAS-ID581-05-5
RxCUI—
ChEMBL IDCHEMBL214332
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDOVF025LA77 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CALCRL
CALCRL
Organism
Homo sapiens
Gene name
CALCRL
Gene synonyms
CGRPR
NCBI Gene ID
Protein name
calcitonin gene-related peptide type 1 receptor
Protein synonyms
calcitonin receptor-like, Calcitonin receptor-like receptor, CGRP type 1 receptor
Uniprot ID
Mouse ortholog
Calcrl (54598)
calcitonin gene-related peptide type 1 receptor (Q9WUP2)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 22,582 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
10 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use